iBio to Report Fiscal 2022 First Quarter Financial Results and Provide Corporate Update on Monday, November 15, 2021

NEXT STORY
Viemed Healthcare Announces Principal Physician Researcher to Present Latest Clinical Findings
PREV STORY
Rubius Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Atossa Therapeutics Begins Enrollment of Phase 2 Clinical Study of Oral Endoxifen in Sweden

author_avatar
NASDAQ Market News

Immunicum AB (publ) Announces Peter Suenaert to Resume Role as Chief Medical Officer

author_avatar
NASDAQ Market News

Infection Control Market Worth $58.2 Billion by 2027- Pre and Post COVID-19 Market Analysis and Industry Forecasts by Meticulous Research®

author_avatar
NASDAQ Market News